A detailed history of Balboa Wealth Partners transactions in Immunic, Inc. stock. As of the latest transaction made, Balboa Wealth Partners holds 12,000 shares of IMUX stock, worth $14,160. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,000
Holding current value
$14,160
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$1.08 - $1.95 $12,960 - $23,400
12,000 New
12,000 $19,000
Q2 2023

Aug 08, 2023

BUY
$1.33 - $2.51 $15,960 - $30,119
12,000 New
12,000 $30,000

Others Institutions Holding IMUX

About IMMUNIC, INC.


  • Ticker IMUX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,565,000
  • Market Cap $36.1M
  • Description
  • Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...
More about IMUX
Track This Portfolio

Track Balboa Wealth Partners Portfolio

Follow Balboa Wealth Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balboa Wealth Partners, based on Form 13F filings with the SEC.

News

Stay updated on Balboa Wealth Partners with notifications on news.